ATE431140T1 - Antiproliferative kombinations-therapie mit satraplatin oder jm118 und docetaxel - Google Patents

Antiproliferative kombinations-therapie mit satraplatin oder jm118 und docetaxel

Info

Publication number
ATE431140T1
ATE431140T1 AT05005380T AT05005380T ATE431140T1 AT E431140 T1 ATE431140 T1 AT E431140T1 AT 05005380 T AT05005380 T AT 05005380T AT 05005380 T AT05005380 T AT 05005380T AT E431140 T1 ATE431140 T1 AT E431140T1
Authority
AT
Austria
Prior art keywords
satraplatin
docetaxel
combination therapy
antiproliferative combination
antiproliferative
Prior art date
Application number
AT05005380T
Other languages
English (en)
Inventor
Katja Wosikowski-Buters
Hemanshu Shah
Maureen Caligiuri
Original Assignee
Gpc Biotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gpc Biotech Ag filed Critical Gpc Biotech Ag
Application granted granted Critical
Publication of ATE431140T1 publication Critical patent/ATE431140T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/282Platinum compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05005380T 2005-03-11 2005-03-11 Antiproliferative kombinations-therapie mit satraplatin oder jm118 und docetaxel ATE431140T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05005380A EP1700598B1 (de) 2005-03-11 2005-03-11 Antiproliferative Kombinations-Therapie mit Satraplatin oder JM118 und Docetaxel

Publications (1)

Publication Number Publication Date
ATE431140T1 true ATE431140T1 (de) 2009-05-15

Family

ID=34934212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05005380T ATE431140T1 (de) 2005-03-11 2005-03-11 Antiproliferative kombinations-therapie mit satraplatin oder jm118 und docetaxel

Country Status (16)

Country Link
US (1) US20090030067A1 (de)
EP (2) EP1700598B1 (de)
JP (1) JP2008532982A (de)
CN (1) CN101137360A (de)
AR (1) AR053338A1 (de)
AT (1) ATE431140T1 (de)
AU (1) AU2006221964A1 (de)
CA (1) CA2600558A1 (de)
DE (1) DE602005014442D1 (de)
DK (1) DK1700598T3 (de)
ES (1) ES2327421T3 (de)
IL (1) IL185679A0 (de)
NO (1) NO20075148L (de)
TW (1) TW200642684A (de)
WO (1) WO2006095016A2 (de)
ZA (1) ZA200708128B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300120B6 (cs) * 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
EP1905439A1 (de) * 2006-09-24 2008-04-02 GPC Biotech AG Nebenbehandlung von metastatischem hormonrefraktärem Prostatakrebs mit Satraplatin
EP1905437A1 (de) * 2006-09-24 2008-04-02 GPC Biotech AG Schmerzbehandlung mit Satraplatin
WO2010121243A1 (en) * 2009-04-17 2010-10-21 University Of Arizona Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
PH12014501639B1 (en) * 2012-01-17 2023-02-22 Tyme Inc Pharmaceutical compositions and methods
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
CN107635574B (zh) 2015-03-30 2021-12-28 桑尼布鲁克研究院 治疗癌症的方法
US10169325B2 (en) 2017-02-09 2019-01-01 International Business Machines Corporation Segmenting and interpreting a document, and relocating document fragments to corresponding sections
CN112789045A (zh) 2018-07-19 2021-05-11 亚莫制药有限公司 用于治疗孤独症的组合物和方法
CN114342478B (zh) 2019-09-06 2024-09-06 埃塔无线公司 用于蜂窝无线电的毫米波芯片组的传输线上的功率管理控制

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6025473A (en) * 1992-10-27 2000-02-15 Queen's University At Kingston Multidrug resistance proteins
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
CA2307393A1 (en) * 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
AU2006221964A1 (en) 2006-09-14
US20090030067A1 (en) 2009-01-29
CN101137360A (zh) 2008-03-05
TW200642684A (en) 2006-12-16
JP2008532982A (ja) 2008-08-21
NO20075148L (no) 2007-12-07
AR053338A1 (es) 2007-05-02
WO2006095016A3 (en) 2007-05-10
EP1700598A1 (de) 2006-09-13
CA2600558A1 (en) 2006-09-14
ES2327421T3 (es) 2009-10-29
EP1861086A2 (de) 2007-12-05
WO2006095016A2 (en) 2006-09-14
ZA200708128B (en) 2008-10-29
DK1700598T3 (da) 2009-08-31
DE602005014442D1 (de) 2009-06-25
IL185679A0 (en) 2008-08-07
EP1700598B1 (de) 2009-05-13

Similar Documents

Publication Publication Date Title
ATE431140T1 (de) Antiproliferative kombinations-therapie mit satraplatin oder jm118 und docetaxel
CY2023026I1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
EP1726795A4 (de) Wabenstrukturkörper und abgasreinigungsvorrichtung
ATE533481T1 (de) Formulierung mit metformin und vildagliptin
CY2017006I2 (el) Αερολυμενες φθοροκινολονες και χρησεις αυτων
DE602006021226D1 (de) Dehnbare absorptionsschicht und absorbierender artikel
DE602006005539D1 (de) Ernährungsschlauch und Schiene
EP1920216A4 (de) Orts-schilder und orientierung
EP1754814A4 (de) Kulierstrick- oder -wirkware mit polyurethanelastomerfaser und herstellungsverfahren dafür
DE602007001645D1 (de) Spielball mit optimal positionierten Kerben und/oder Erhöhungen
DE602006011179D1 (de) Fahrzeug mit steuervorrichtung und fahrzeugsteuerverfahren
DE602005021918D1 (de) Endloskörper und raupenvorrichtung
DE602005003186D1 (de) Fluorkopolymer und dessen Verwendung
DE602005022220D1 (de) Uhrwerk und display
DE502005010311D1 (de) Einrichtung zur herstellung und/oder montage von gütern
DE602005019131D1 (de) Spielprogramm und Spielvorrichtung
DE50305034D1 (de) Uhr mit Rattrapantenfunktion und entsprechender Rattrapanten-Mechanismus
EP1802706A4 (de) Verbundwerkstoff und lichtemittierendes element
IL179533A0 (en) Treatment with cisplatin and an egfr-inhibitor
DE602006000779D1 (de) Planetenreibradantriebsvorrichtung und Lenkeinrichtung mit einer solchen
DE602006018166D1 (de) Polyrotaxanhaltige lösung und verwendung davon
DE602005023325D1 (de) Harzzusammensetzung und formkörper daraus
DE602005013187D1 (de) Teil oder vliesstoff und stromkreiskomponenten
DE602005022995D1 (de) Arylsulfone und damit verbundene verwendungen
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1700598

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1700598

Country of ref document: EP

REN Ceased due to non-payment of the annual fee